EGTA inhibition of DNase activity in commercial lysostaphin preparations
Malatesta, M.L.; Heath, H.E.; LeBlanc, P.A.; Sloan, G.L.
Biotechniques 12(1): 70; 72
1992
ISSN/ISBN: 0736-6205 PMID: 1734926 Document Number: 391020
Document emailed within 1 workday
Related Documents
Borsuk, E.A.; Vorob'eva, M.S.; Ebralidze, L.K. 1991: The evaluation of a commercial EIA test system for determining the specific activity of antiherpetic preparations Voprosy Virusologii 36(2): 137-140Pukhova, G.G. 1971: Inhibition of pancreatic DNase by hemoglobin Ukrains'kyi Biokhimichnyi Zhurnal 43(2): 240-242
Pruzanski, W.; Saito, S.; Nitzan, D.W. 1983: The influence of lysostaphin on phagocytosis, intracellular bactericidal activity, and chemotaxis of human polymorphonuclear cells Journal of Laboratory and Clinical Medicine 102(2): 298-305
Firoz, M.; Graber, M. 2001: Bioavailability of US commercial magnesium preparations Magnesium Research 14(4): 257-262
Gurtovenko, V.N.; Filippenko, L.I.; Dmitrieva, Z.D. 1974: DNase activity of staphylococci in comparison with other signs of their pathogenicity Mikrobiolohichnyi Zhurnal 36(2): 149-152
Reitz, M.; Knitza, R.; Lanz, E. 1993: Increasing DNase I activity after exposure of isolated DNA to halothane Arzneimittel-Forschung 43(2): 92-94
Khursin, N.E. 1976: Effect of hypoxia on serum DNase activity in animals Fiziolohichnyi Zhurnal 22(3): 408-410
Ivannik, B.P.; Riabchenko, N.I. 1982: Effect of cycloheximide on the alkaline and acid DNAse activity in rat cells Biokhimiia 47(5): 746-751
Liu, M.Y.; Chen, J.Y.; Yang, C.S. 1984: Activity of DNase associated with replication of Epstein-Barr virus in NPC-204 cells Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 17(3): 121-130
Sarukhanova, L.E.; Volina, E.G.; Levina, L.F. 1995: A comparative study of the DNAse activity of leptospirae on solid nutrient media Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 11-12
Reitz, M.; Köllner, D.; Preiss, U.; Gutjahr, P. 1996: Reduced neutral DNase activity in the urine of children after cytostatic therapy Arzneimittel-Forschung 46(4): 438-441
O'Neill, P.A.; Woodson, D.L.; Mackler, B.F. 1978: EAC rosette-forming lymphocytes in commercial preparations of sheep erythrocytes Journal of Immunology 121(6): 2586-2587
Chakrabarty, A.K.; Friedman, H. 1970: Nucleases in immunity. I. the effect of immunization on RNase and DNase activity in lymphoid tissues Clinical and Experimental Immunology 6(4): 609-618
Viazov, S.O.; Doroshenko, N.V.; Khatkevich, S.P.; Reznikov, I.P.; Minakova, L.V. 1983: Antibodies to hepatitis a and B viral antigens in commercial gamma-globulin preparations Voprosy Virusologii 28(5): 542-545
Navarro, M.A.; Raei, N.; Torres, F.; Granero, L.; García-Zaragoza, E.; Esplugues, J.V.; Esteban Peris, J. 1998: Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration Gastroenterologia y Hepatologia 21(2): 63-70
Grosshans, E.; Samsoen, M. 1981: Topical preparations combining a dermocorticoid and an antifungal agent and their commercial relevance Annales de Dermatologie et de Venereologie 108(5): 481-482
López Fernández, M.F.; López Borrasca, A.; López Berges, C.; Batlle Fonrodona, J. 1985: Thrombin-mediated interaction between platelets and FvW present in commercial preparations and cryoprecipitate Sangre 30(5): 871-879
Eggeling, B.; Lechler, E.; Asbeck, F. 1975: Examination of commercial prothrombin-complex (PPSB) preparations for activated factors Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1140-1144
Hitier, Y. 1970: Comparison of effects of avitaminosis C on activity of acid DNase of testis in the young and adult guinea pig Archives des Sciences Physiologiques 24(3): 323-330
Migunov, V.N.; Pozina, I.M.; Maksimova, Z.I.; Chernobel', T.P.; Shinkarenko, A.I. 1985: Effect of the stage of isoelectric sedimentation on the quality of commercial preparations of gamma globulin Gematologiia i Transfuziologiia 30(10): 48-51